Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Delayed Nyse
Other stock markets
 17:51:08 17/05/2024 BST 		5-day change 1st Jan Change
1.105 USD -2.21% Intraday chart for NKGen Biotech, Inc. -10.40% -86.69%
04-29 Nkgen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapy in Parkinson's Disease CI
04-29 NKGen Biotech, Inc. announced that it has received $0.55 million in funding from FirstFire Capital Management LLC, Meteora Capital, LLC, Glazer Capital, LLC, Meteora Strategic Capital, LLC, Sandia Investment Managment LP CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 3.580 3.580 3.470
Spread/Res.-69.13%-69.13%-68.16%
Spread/Supp.+24.16%+24.16%-3.07%
Support 0.8900 0.8900 1.140
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.